Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Applied Therapeutics Inc’s stock clocked out at $0.54, up 5.45% from its previous closing price of $0.51. In other words, the price has increased by $5.45 from its previous closing price. On the day, 1.1 million shares were traded.
Ratios:
To gain a deeper understanding of APLT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.06 and its Current Ratio is at 1.06. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.29.
On December 02, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $13 to $2.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on November 29, 2024, whereas the target price for the stock was revised from $12 to $4.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 04 ’25 when Perfetti Riccardo sold 10,366 shares for $0.44 per share. The transaction valued at 4,561 led to the insider holds 890,409 shares of the business.
Funtleyder Leslie D. sold 14,502 shares of APLT for $6,381 on Mar 04 ’25. The insider now owns 390,459 shares after completing the transaction at $0.44 per share. On Mar 04 ’25, another insider, Chinoporos Constantine, who serves as the insider of the company, sold 447 shares for $0.44 each. As a result, the insider received 197 and left with 271,436 shares of the company.
Stock Price History:
Over the past 52 weeks, APLT has reached a high of $10.62, while it has fallen to a 52-week low of $0.43. The 50-Day Moving Average of the stock is -13.93%, while the 200-Day Moving Average is calculated to be -88.32%.
Shares Statistics:
A total of 116.36M shares are outstanding, with a floating share count of 92.20M. Insiders hold about 20.76% of the company’s shares, while institutions hold 84.07% stake in the company.
Earnings Estimates
The market rating for Applied Therapeutics Inc (APLT) is a result of the insights provided by 4.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.16 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$1.23 and -$1.52 for the fiscal current year, implying an average EPS of -$1.33. EPS for the following year is -$0.59, with 4.0 analysts recommending between -$0.46 and -$0.71.
Revenue Estimates
For the next quarter, 3 analysts are estimating revenue of $12.32M. There is a high estimate of $30.4M for the next quarter, whereas the lowest estimate is $2.8M.
A total of 4 analysts have provided revenue estimates for APLT’s current fiscal year. The highest revenue estimate was $800k, while the lowest revenue estimate was $456k, resulting in an average revenue estimate of $553k. In the same quarter a year ago, actual revenue was $9.99MBased on 4 analysts’ estimates, the company’s revenue will be $15.14M in the next fiscal year. The high estimate is $39.4M and the low estimate is $5M.
